Clinical Trials in Florida

Showing 6181-6200 of 9,710 trials

Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia

NCT00596011

The purpose of this study was to determine whether the daily consumption of decaffeinated green tea catechins (Polyphenon E®) for 1 year reduces the rate of progression to prostate cancer (PCa) in men diagnosed with HGPIN or ASAP. The aim was to recruit and treat 240 (120 men/arm) men diagnosed with the prostate condition HGPIN or ASAP with a capsule form of standardized green tea extract called Polyphenon E or placebo for a 12-month period and see if it can prevent progression of the prostate condition to prostate cancer. Investigators wanted to see if Polyphenon E reduces lower urinary tract symptoms and if this can be taken safely over one year. Investigators wanted to study how Polyphenon E is able to slow the progression to prostate cancer, or the mechanism of action of Polyphenon E. If the safety and the effects of Polyphenon E on slowing down the progression of prostate cancer is shown in our study, this will be a safe way of treating men who are at high risk or men like you who have a prostate condition that increases your chances of getting prostate cancer, so that we can prevent prostate cancer in the future.

Prostatic Hyperplasia

H. Lee Moffitt Cancer Center and Research Institute97 participantsStarted Nov 2007

Gainesville, Florida, United States • Jacksonville, Florida, United States • Lakeland, Florida, United States +7 more locations

UNKNOWNPhase 238 miles

Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris

NCT03900676

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Dose-ranging Study in the Treatment of Acne Vulgaris,

Acne Vulgaris

Vyome Therapeutics Inc.480 participantsStarted Apr 2019

Ontario, California, United States • Sherman Oaks, California, United States • Brandon, Florida, United States +9 more locations

Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia

Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris

Find Trials by Condition in Florida

ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation

Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers

Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease

PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment

An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation

Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Study of Ramucirumab in Ovarian Cancer

A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"

Building an Optimal Hand Hygiene Bundle

Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa

A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)

Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma